Filipe Marques
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Filipe Marques has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Andriy Luzhetskyy
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbruecken, Germany
2 shared publications - Ana Fernandes
ICBAS, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.
1 shared publication - Ana Maria Tomas
I3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, 4200-135, Porto, Portugal
1 shared publication - Eduardo Rocha
Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
1 shared publication - Iva Fernandes
LAQV-REQUIMTE, Chemistry and Biochemistry Department, Faculty of Sciences, University of Porto, Rua do Campo Alegre 689, 4169-007 Porto, Portugal
1 shared publication - Joana Moreira Marques
Instituto de Investigação e Inovação em Saúde and IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.
1 shared publication
Latest Publications
- 1 November 2020
- Published by Elsevier in Metabolic Engineering
- Vol. 62, 221-234
Engineering Corynebacterium glutamicum with a comprehensive genomic library and phage-based vectors
- 1 November 2020
- Published by Elsevier in Metabolic Engineering
- Vol. 62, 221-234
Engineering Corynebacterium glutamicum with a comprehensive genomic library and phage-based vectors
- 1 September 2018
- Published by Elsevier in Metabolic Engineering
- Vol. 49, 299-315
Secondary metabolites overproduction through transcriptional gene cluster refactoring
- 1 September 2018
- Published by Elsevier in Metabolic Engineering
- Vol. 49, 299-315
Secondary metabolites overproduction through transcriptional gene cluster refactoring
- Open Access
- 18 December 2015
- Published by Springer Nature in Parasites & Vectors
- Vol. 8 (1) , 1-12
Studies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection
Visceral leishmaniasis is a severe and potentially fatal disease caused by protozoa of the genus Leishmania, transmitted by phlebotomine sandflies. In Europe and the Mediterranean region, L. infantum is the commonest agent of visceral leishmaniasis, causing a wide spectrum of clinical manifestations, including asymptomatic carriage, cutaneous lesions and severe visceral disease. Visceral leishmaniasis is more frequent in immunocompromised individuals and data obtained in experimental models of infection have highlighted the importance of the host immune response, namely the efficient activation of host’s macrophages, in determining infection outcome. Conversely, few studies have addressed a possible contribution of parasite variability to this outcome. In this study, we compared three isolates of L. infantum regarding their capacity to grow in the organs of mice, the way they activate the host’s macrophages and other components of the immune response and also their capacity to cope with host’s antimicrobial mechanisms, namely reactive oxygen and nitrogen species. We found that the three parasite strains significantly differed regarding the degree to which they induced nitric oxide synthase (NOS2) and arginase expression in infected macrophages and the pattern of cytokine production they induced in the host, resulting in different degrees of inflammatory response in infected livers. Additionally, the three strains also significantly differed in their in vitro susceptibility to reactive oxygen and nitrogen species. This variability was reflected in the capacity of each strain to persist and proliferate in the organs of wild-type as well as NOS2- and phagocyte oxidase- deficient mice. The results obtained in this study show that parasite strain variability is an important determinant of disease outcome in L. infantum visceral leishmaniasis, with relevant implications for studies on host-pathogen interaction and also for leishmanicidal drug development.
- 18 December 2015
- Published by Springer Nature in Parasites & Vectors
- Vol. 8 (1) , 1-12
Open AccessStudies in the mouse model identify strain variability as a major determinant of disease outcome in Leishmania infantum infection
Visceral leishmaniasis is a severe and potentially fatal disease caused by protozoa of the genus Leishmania, transmitted by phlebotomine sandflies. In Europe and the Mediterranean region, L. infantum is the commonest agent of visceral leishmaniasis, causing a wide spectrum of clinical manifestations, including asymptomatic carriage, cutaneous lesions and severe visceral disease. Visceral leishmaniasis is more frequent in immunocompromised individuals and data obtained in experimental models of infection have highlighted the importance of the host immune response, namely the efficient activation of host’s macrophages, in determining infection outcome. Conversely, few studies have addressed a possible contribution of parasite variability to this outcome. In this study, we compared three isolates of L. infantum regarding their capacity to grow in the organs of mice, the way they activate the host’s macrophages and other components of the immune response and also their capacity to cope with host’s antimicrobial mechanisms, namely reactive oxygen and nitrogen species. We found that the three parasite strains significantly differed regarding the degree to which they induced nitric oxide synthase (NOS2) and arginase expression in infected macrophages and the pattern of cytokine production they induced in the host, resulting in different degrees of inflammatory response in infected livers. Additionally, the three strains also significantly differed in their in vitro susceptibility to reactive oxygen and nitrogen species. This variability was reflected in the capacity of each strain to persist and proliferate in the organs of wild-type as well as NOS2- and phagocyte oxidase- deficient mice. The results obtained in this study show that parasite strain variability is an important determinant of disease outcome in L. infantum visceral leishmaniasis, with relevant implications for studies on host-pathogen interaction and also for leishmanicidal drug development.
- 1 December 2013
- Published by Elsevier in Food Chemistry
- Vol. 141 (3) , 2923-2933
Antioxidant and antiproliferative properties of methylated metabolites of anthocyanins
- 1 December 2013
- Published by Elsevier in Food Chemistry
- Vol. 141 (3) , 2923-2933
Antioxidant and antiproliferative properties of methylated metabolites of anthocyanins